| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13160* | 2021 |
| Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study M Pollán, B Pérez-Gómez, R Pastor-Barriuso, J Oteo, MA Hernán, ... The Lancet 396 (10250), 535-544, 2020 | 2011 | 2020 |
| Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world? A Beceiro, M Tomás, G Bou Clinical microbiology reviews 26 (2), 185-230, 2013 | 1182 | 2013 |
| Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective … B Gutiérrez-Gutiérrez, E Salamanca, M de Cueto, PR Hsueh, P Viale, ... The Lancet Infectious Diseases 17 (7), 726-734, 2017 | 479 | 2017 |
| Characterization of a Nosocomial Outbreak Caused by a Multiresistant Acinetobacter baumannii Strain with a Carbapenem-Hydrolyzing Enzyme: High-Level Carbapenem … G Bou, G Cerveró, MA Dominguez, C Quereda, J Martínez-Beltrán Journal of clinical microbiology 38 (9), 3299-3305, 2000 | 479 | 2000 |
| OXA-24, a Novel Class D β-Lactamase with Carbapenemase Activity in an Acinetobacter baumanniiClinical Strain G Bou, A Oliver, J Martínez-Beltrán Antimicrobial agents and chemotherapy 44 (6), 1556-1561, 2000 | 479 | 2000 |
| Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system A Beceiro, E Llobet, J Aranda, JA Bengoechea, M Doumith, M Hornsey, ... Antimicrobial agents and chemotherapy 55 (7), 3370-3379, 2011 | 449 | 2011 |
| Complete DNA sequence of yeast chromosome XI B Dujon, D Alexandraki, B Andre, W Ansorge, V Baladron, JPG Ballesta, ... Nature Publishing Group 369 (6479), 371-378, 1994 | 445 | 1994 |
| Horizontal transfer of the OXA-24 carbapenemase gene via outer membrane vesicles: a new mechanism of dissemination of carbapenem resistance genes in Acinetobacter baumannii C Rumbo, E Fernández-Moreira, M Merino, M Poza, JA Mendez, ... Antimicrobial agents and chemotherapy 55 (7), 3084-3090, 2011 | 381 | 2011 |
| Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort J Torre-Cisneros, A Doblas, JM Aguado, R San Juan, M Blanes, ... Clinical infectious diseases 48 (12), 1657-1665, 2009 | 327 | 2009 |
| Métodos de identificación bacteriana en el laboratorio de microbiología G Bou, A Fernández-Olmos, C García, JA Sáez-Nieto, S Valdezate Enfermedades infecciosas y microbiología clínica 29 (8), 601-608, 2011 | 309 | 2011 |
| Cloning, Nucleotide Sequencing, and Analysis of the Gene Encoding an AmpC β-Lactamase in Acinetobacter baumannii G Bou, J Martínez-Beltrán Antimicrobial agents and chemotherapy 44 (2), 428-432, 2000 | 301 | 2000 |
| Evaluation of different methods for detecting methicillin (oxacillin) resistance in Staphylococcus aureus D Velasco, M del Mar Tomas, M Cartelle, A Beceiro, A Perez, F Molina, ... Journal of Antimicrobial Chemotherapy 55 (3), 379-382, 2005 | 292 | 2005 |
| Isolation and Characterization of Potentially Pathogenic Antimicrobial-Resistant Escherichia coli Strains from Chicken and Pig Farms in Spain P Cortés, V Blanc, A Mora, G Dahbi, JE Blanco, M Blanco, C López, ... Applied and environmental microbiology 76 (9), 2799-2805, 2010 | 284 | 2010 |
| OXA-235, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii PG Higgins, FJ Pérez-Llarena, E Zander, A Fernández, G Bou, H Seifert Antimicrobial agents and chemotherapy 57 (5), 2121-2126, 2013 | 278 | 2013 |
| Relationship between quorum sensing and secretion systems RT Pena, L Blasco, A Ambroa, B González-Pedrajo, L Fernández-García, ... Frontiers in microbiology 10, 455464, 2019 | 267 | 2019 |
| Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii C Rumbo, E Gato, M López, C Ruiz de Alegría, F Fernández-Cuenca, ... Antimicrobial agents and chemotherapy 57 (11), 5247-5257, 2013 | 247* | 2013 |
| Biological cost of different mechanisms of colistin resistance and their impact on virulence in Acinetobacter baumannii A Beceiro, A Moreno, N Fernández, JA Vallejo, J Aranda, B Adler, ... Antimicrobial agents and chemotherapy 58 (1), 518-526, 2014 | 245 | 2014 |
| Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone J Gavalda, O Len, JM Miró, P Munoz, M Montejo, A Alarcón, ... Annals of internal medicine 146 (8), 574-579, 2007 | 242 | 2007 |
| Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection M del Mar Tomas, M Cartelle, S Pertega, A Beceiro, P Llinares, D Canle, ... Clinical microbiology and infection 11 (7), 540-546, 2005 | 239 | 2005 |
